X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Cancer Diagnostics Company List

Mordor Intelligence expert advisors identify the Top 5 Cancer Diagnostics companies and the other top companies based on 2024 market position. Get access to the business profiles of top 14 Cancer Diagnostics companies, providing in-depth details on their company overview, key products and services, financials, recent developments and strategic moves.

Cancer Diagnostics Top Companies

trophy

Cancer Diagnostics Market

Top 5 Cancer Diagnostics Companies

  • arrow

    Abbott Laboratories Inc.

  • arrow

    F. Hoffmann-La Roche Ltd

  • arrow

    Thermo Fisher Scientific Inc.

  • arrow

    Illumina Inc.

  • arrow

    bioMérieux SA

 Cancer Diagnostics Market Major Players

Source: Mordor Intelligence

*Top companies in "Cancer Diagnostics Market" based on their market share in 2024, sorted in no particular order

Get market shares and tailor-made intelligence on top players.
Get Free Proposal

Top 5 Cancer Diagnostics Companies

Global Overview Operations in this Market Strengths Strategies & Outlook
Abbott Laboratories Inc.
Robust portfolio including novel tests for various cancer types. Develops innovative tests that provide timely cancer detection and treatment guidance. Strong portfolio of diagnostic tests supports diverse cancer detection needs. Emphasis on partnerships enhances market penetration and product development.
F. Hoffmann-La Roche Ltd
Offers comprehensive diagnostics solutions encompassing multiple cancer biomarkers. Extensive portfolio in molecular diagnostics and personalized medicine. Robust research investments enhance innovative diagnostics and treatment solutions. Investments in R&D and personalized medicine drive product innovation.
Thermo Fisher Scientific Inc.
Broad range of diagnostic tools supporting precision medicine in oncology. Offers comprehensive diagnostic solutions, including advanced genomic analysis. Comprehensive product offerings cater to multiple stages of cancer diagnostics. Commitment to expanding diagnostic capabilities through strategic acquisitions.
Illumina Inc.
Leads in next-generation sequencing technologies for personalized cancer diagnostics. Leads in next-generation sequencing technology for cancer genomics. Pioneering technology in sequencing provides crucial insights in personalized medicine. Next-generation sequencing technology fuels growth in personalized cancer diagnostics.
bioMérieux SA
Employs advanced microbiological testing in cancer diagnostics and monitoring. Provides diagnostics with a focus on infectious diseases related to cancer. Established brand recognized for effective infectious disease and cancer tests. Focus on infectious disease testing expands portfolio and market reach.
Uncover market estimates, industry Trends and competitive landscape in a single report
Download PDF

Other Top Cancer Diagnostics Companies

Global Overview Operations in this Market Strengths Strategies & Outlook
Siemens Healthineers
Innovative imaging technologies enhancing early cancer detection capabilities. Engages in developing innovative diagnostic solutions through advanced technologies. Possesses advanced technological capabilities that streamline diagnostic processes effectively. Integration of AI and imaging solutions enhances diagnostic accuracy.
GE Healthcare
Utilizes advanced imaging and monitoring solutions for oncology support. Diverse technologies enable personalized cancer detection and treatment solutions. Strong innovation pipeline with advanced imaging and diagnostic technologies. Development of innovative imaging technologies supports early cancer detection.
Hologic Inc.
Specializes in women's health with a range of cancer screening technologies. Focuses on innovative screening and diagnostic solutions to improve patient outcomes. Strong product pipeline and innovative technologies for early cancer detection. Diversification into women's health strengthens cancer diagnosis capabilities.
Bio-Rad Laboratories Inc.
Provides tools for molecular diagnostics in oncology and personalized medicine. Engaging in strategic partnerships for innovative diagnostic solutions and technologies. Strong portfolio of innovative diagnostic products enhances competitive positioning. Broad range of diagnostic tests fosters competitive positioning in the market.
Agilent Technologies Inc.
Integrates genomic technologies for versatile applications in cancer diagnostics. Focused on innovative solutions and strategic partnerships for market growth. Established presence in innovative diagnostics and strong R&D capabilities. Innovative bio-analyses attract research collaborations for cancer diagnostics.
Cancer Diagnostics Inc.
Focuses on developing assays targeting specific cancer biomarkers. Leverages advanced technologies for precise and early cancer detection methodologies. Diverse product offerings supported by advanced technological capabilities in diagnostics. Niche offerings focus on emerging technologies in genetic diagnostics.
Myriad Genetic Laboratories Inc.
Focuses on genetic testing for inherited cancer risks. Focus on genetic testing and personalized medicine drives operational strategies. Strong portfolio of proprietary genetic tests enhances competitive edge. Genetic testing services are integral to personalized cancer treatment plans.
Qiagen
Delivers molecular quality control solutions for improved cancer detection. Focuses on molecular diagnostics to improve cancer detection methods. Strong portfolio of validated diagnostic tests enhances market competitiveness. Partnerships with biopharma companies enhance test development and market access.

Get hard to find intelligence on your customers, suppliers, partners and competitors-backed with on-the-gorund-data.

  • In-depth company profiles
  • Segment level market shares
  • Strategy assessment and SWOT analysis
  • Product portfolio and pricing details
  • Identification and shortlisting of potential partners
  • Need analysis and unmet needs
  • Purchase and usage behavior
  • Partner/customer feedback and satisfaction

Competitive Analysis of Best Companies in Cancer Diagnostics Market

Cancer Diagnostics Market: Competitive Landscape

Market Characteristics: The Cancer Diagnostics Market is characterized by a fairly consolidated environment, with several dominant global players exerting significant influence. Companies such as Abbott Laboratories Inc. and F. Hoffmann-La Roche Ltd lead the market, leveraging advanced technologies and extensive distribution networks. This sector primarily consists of both conglomerates and specialized companies, where conglomerates often possess a broader range of capabilities, while specialized firms focus intensely on innovative diagnostic solutions. The landscape reveals a mix of established firms and emerging entities, contributing to a dynamic market scenario.

Major Players' Characteristics: In this market, major companies—including Siemens Healthineers, Thermo Fisher Scientific Inc., and GE Healthcare—stand out for their technological prowess and diverse product offerings. Hologic Inc. and Illumina Inc. have made notable advancements in molecular diagnostics and genomic solutions, pushing the envelope in precision medicine. Alongside these players, Bio-Rad Laboratories Inc. and Agilent Technologies Inc. offer a comprehensive portfolio of testing products and services that strengthen their positions. BioMérieux SA and Cancer Diagnostics Inc. are recognized for their contributions to laboratory performance and innovative diagnostic platforms.

Trends and Strategies: Major trends shaping the Cancer Diagnostics Market include the increasing adoption of liquid biopsy techniques and advancements in personalized medicine. Market players can capitalize on these trends by investing in R&D and fostering partnerships to enhance their technological capabilities. Furthermore, embracing digital technologies and integrating artificial intelligence into diagnostic processes may provide substantial competitive advantages. To succeed, companies should also focus on expanding their geographic footprint and diversifying their product lines to meet the evolving needs of healthcare providers.

Explore More

In-depth Insights on the Top 10 Cancer Diagnostics Companies and more...

Cancer Diagnostics Companies

  • Abbott Laboratories Inc.
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Hologic Inc.
  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies Inc.
  • Biomeriuex SA
  • Cancer Diagnostic Inc.
  • Myriad Genetic Laboratories Inc.
  • Qiagen
  • Agilent Technologies, Inc.

Insights Covered

  • Global Level Overview
  • Market Level Overview
  • Core Business Segmengts
  • Financials
  • Employee Headcount
  • Market Rank and Market Share
  • Products and Services
  • Recent Developments
  • Key Strategic Moves
  • List Of Companies

Cancer Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)